List of works - Jun-Ho Cho

Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia

scientific article published on 15 November 2019

An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type Ia

scientific article published on 22 February 2019

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia.

scientific article

Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy.

scientific article published on 13 March 2017

Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: a review

scientific article published on 31 May 2020

Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage

scientific article published on 06 March 2019

Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors

scientific article published on 10 January 2017

Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

scientific article published on 12 March 2018

Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism.

scientific article published on 9 December 2003

Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI

scientific article published on 24 September 2019

Liver-directed gene therapy for murine glycogen storage disease type Ib.

scientific article published on 21 August 2017

Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity

scientific article

Molecular biology and gene therapy for glycogen storage disease type Ib.

scientific article published on 16 April 2018

PRMT1 negatively regulates activation-induced cell death in macrophages by arginine methylation of GAPDH

scientific article published on 14 April 2018

Positive regulation of ASK1-mediated c-Jun NH(2)-terminal kinase signaling pathway by the WD-repeat protein Gemin5

scientific article

Recent development and gene therapy for glycogen storage disease type Ia ⬇️

scientific article published on 01 September 2017

Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia

scientific article published on 08 May 2018

List of works by Jun-Ho Cho

Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia

An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type Ia

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia.

Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy.

Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: a review

Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage

Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors

Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism.

Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI

Liver-directed gene therapy for murine glycogen storage disease type Ib.

Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity

Molecular biology and gene therapy for glycogen storage disease type Ib.

PRMT1 negatively regulates activation-induced cell death in macrophages by arginine methylation of GAPDH

Positive regulation of ASK1-mediated c-Jun NH(2)-terminal kinase signaling pathway by the WD-repeat protein Gemin5

Recent development and gene therapy for glycogen storage disease type Ia ⬇️

Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia